Aptevo Therapeutics (APVO) Misses Q3 EPS by 15c
Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.
Aptevo Therapeutics (NASDAQ: APVO) reported Q3 EPS of ($1.50), $0.15 worse than the analyst estimate of ($1.35).
For earnings history and earnings-related data on Aptevo Therapeutics (APVO) click here.